Circuit-Based DBS for Parkinson's Disease (NCT05658302)

Circuit-Based Deep Brain Stimulation for Parkinson's Disease

Overview

Circuit-Based Deep Brain Stimulation (DBS) represents a paradigm shift in [Parkinson's disease](/diseases/parkinsons-disease) treatment, moving from fixed stimulation patterns to adaptive, closed-loop systems that respond to neural circuit activity. This observational study (NCT05658302) conducted by the University of Minnesota investigates how targeted electrical modulation of specific brain circuits affects motor and cognitive function in Parkinson's disease patients.

Trial Details

| Parameter | Value |
|-----------|-------|
| NCT Number | NCT05658302 |
| Status | Recruiting |
| Study Type | Observational |
| Sponsor | University of Minnesota |
| Enrollment | 30 participants (estimated) |
| Start Date | March 28, 2023 |
| Completion Date | March 1, 2028 |
| Location | Minneapolis, Minnesota, United States |

Mechanism of Action

Circuit-Based DBS Approach

Traditional DBS delivers continuous high-frequency electrical stimulation to brain regions like the [subthalamic nucleus](/cell-types/subthalamic-nucleus) or [globus pallidus internus](/cell-types/globus-pallidus). Circuit-Based DBS advances this by:

Neural Circuit Mapping — Identifying specific circuits that contribute to motor symptoms

Adaptive Stimulation — Modulating stimulation based on real-time neural activity

Personalized Targeting — Tailoring electrode placement to individual circuit anatomy

Research Objectives

...

Circuit-Based Deep Brain Stimulation for Parkinson's Disease

Overview

Circuit-Based Deep Brain Stimulation (DBS) represents a paradigm shift in [Parkinson's disease](/diseases/parkinsons-disease) treatment, moving from fixed stimulation patterns to adaptive, closed-loop systems that respond to neural circuit activity. This observational study (NCT05658302) conducted by the University of Minnesota investigates how targeted electrical modulation of specific brain circuits affects motor and cognitive function in Parkinson's disease patients.

Trial Details

| Parameter | Value |
|-----------|-------|
| NCT Number | NCT05658302 |
| Status | Recruiting |
| Study Type | Observational |
| Sponsor | University of Minnesota |
| Enrollment | 30 participants (estimated) |
| Start Date | March 28, 2023 |
| Completion Date | March 1, 2028 |
| Location | Minneapolis, Minnesota, United States |

Mechanism of Action

Circuit-Based DBS Approach

Traditional DBS delivers continuous high-frequency electrical stimulation to brain regions like the [subthalamic nucleus](/cell-types/subthalamic-nucleus) or [globus pallidus internus](/cell-types/globus-pallidus). Circuit-Based DBS advances this by:

Neural Circuit Mapping — Identifying specific circuits that contribute to motor symptoms

Adaptive Stimulation — Modulating stimulation based on real-time neural activity

Personalized Targeting — Tailoring electrode placement to individual circuit anatomy

Research Objectives

The trial focuses on understanding:

• How reach-related neural modulation differs in PD patients with DBS
• The relationship between cognitive task performance (N-back) and motor circuits
• How rigidity and bradykinesia assessments correlate with circuit-level changes

Outcome Measures

Primary Outcomes

• Reach-related modulation — Neural activity changes during reaching movements
• N-back task trials — Cognitive performance assessments
• Rigidity and bradykinesia assessments — Standard motor symptom evaluations

Significance for Parkinson's Disease

Circuit-Based DBS represents the next evolution in [deep brain stimulation](/therapeutics/deep-brain-stimulation) therapy:

Adaptive Therapy — Closed-loop systems that adjust stimulation based on patient state

Reduced Side Effects — More precise targeting may minimize adverse effects

Improved Efficacy — Circuit-specific modulation may enhance motor symptom control

Cognitive Benefits — Understanding circuit involvement may lead to non-motor symptom treatment

Deep Brain Stimulation Background

Evolution of DBS Technology

Deep brain stimulation has evolved significantly since its FDA approval:

First Generation ( Conventional DBS):

• Continuous high-frequency stimulation
• Fixed parameters
• Single brain target

Second Generation ( Adaptive DBS):

• Responsive to patient state
• Closed-loop systems
• Real-time modulation

Third Generation ( Circuit-Based DBS):

• Identifies specific circuits
• Personalized targeting
• Cognitive-motor integration

Circuit Dysfunction in PD

Parkinson's disease involves dysfunction in multiple motor circuits:

Basal Ganglia Circuits:

• Motor selection circuit
• Oculomotor circuit
• Prefrontal circuits

Cortical Involvement:

• Motor cortex
• Premotor cortex
• Supplementary motor area

Neural Circuit Mapping

This trial maps circuits using:

Recording Methods:

• Intracranial electrodes
• Surface EMG
• Kinematic tracking

Analysis Approaches:

• Reach-related modulation
• N-back cognitive tasks
• Motor assessment correlation

Beta-Band Oscillations in PD

Pathological Synchronization

In Parkinson's disease, the basal ganglia exhibit abnormal oscillatory activity that correlates with motor symptoms:

Beta-Band Activity (13-35 Hz):

• Elevated in the [subthalamic nucleus](/cell-types/subthalamic-nucleus) and [globus pallidus](/cell-types/globus-pallidus)
• Correlates with bradykinesia and rigidity severity
• Suppressed by dopaminergic medication and conventional DBS
• Acts as biomarker for adaptive stimulation systems

Pathological Mechanisms:

• Excessive synchronization of parkinsonian basal ganglia neurons
• Loss of normal rhythmic patterning in motor circuits
• Disrupted information encoding in cortico-basal ganglia loops
• Correlation with akinesia and reduced movement initiation

Therapeutic Implications:

• Beta-band power serves as control signal for adaptive DBS
• Real-time monitoring enables closed-loop stimulation
• Reduction in beta activity predicts clinical improvement
• Individual beta dynamics inform personalized parameter selection

Alpha-Band Activity

Tremor-Correlated Oscillations:

• Alpha-band (8-12 Hz) oscillations correlate with resting tremor
• Phase-amplitude coupling between alpha and beta bands
• Different frequency bands encode different symptoms
• Multi-band analysis improves symptom tracking

Patient Selection and Surgical Considerations

DBS Candidate Evaluation

Eligibility Assessment:

• Movement disorder neurologist evaluation
• Neuropsychological testing for cognitive function
• Neuroimaging for target planning
• Medical optimization for surgery

Preoperative Workup:
| Test | Purpose |
|------|---------|
| MRI brain | Structural assessment, target planning |
| CT brain | Precise electrode trajectory planning |
| DaTscan | Confirm dopaminergic deficit |
| Neuropsych battery | Cognitive baseline, risk assessment |
| Medication review | Optimize pre-surgical therapy |

Surgical Procedure

Electrode Implantation:

• Frame-based or frameless stereotactic systems
• Microelectrode recording for target refinement
• Macro stimulation test for efficacy
• Bilateral or unilateral implantation

Postoperative Phases:

• Healing period (2-4 weeks)
• Initial programming (4-8 weeks)
• Optimization phase (3-6 months)
• Long-term maintenance

Programming and Parameter Optimization

Stimulation Paradigms

Conventional High-Frequency Stimulation:

• Frequency: 130-180 Hz
• Pulse width: 60-120 μs
• Amplitude: 1-5 V
• Continuous delivery

Low-Frequency Stimulation:

• Alternative for speech/gait side effects
• May worsen rigidity in some patients
• Useful for specific symptom profiles

Burst Stimulation:

• Intermittent high-frequency bursts
• May reduce side effects
• Under investigation for cognitive symptoms

Adaptive DBS Algorithms

Signal Processing Pipeline:

Neural signal acquisition (LFP from implanted electrodes)

Feature extraction (spectral power in target bands)

Threshold detection (exceeding symptom-correlated levels)

Control algorithm (adjust stimulation parameters)

Feedback loop (continuous optimization)

Control Strategies:

• Threshold-triggered (on/off based on biomarker level)
• Proportional (stimulation intensity scales with biomarker)
• Predictive (anticipate symptom fluctuations)
• Multi-modal (combine multiple biomarkers)

Clinical Outcomes and Quality of Life

Motor Symptom Control

Targeted Outcomes:

• Improvement in MDS-UPDRS Part III scores (typically 40-60%)
• Reduced medication requirements
• Improved motor fluency and timing
• Enhanced movement initiation

Specific Assessments:

• Finger tapping (bradykinesia)
• Finger to nose (coordination)
• Gait and posture evaluation
• Speech and swallowing function

Non-Motor Symptoms

Cognitive Effects:

• Variable effects on executive function
• Potential improvement in processing speed
• Risk of worsening in susceptible individuals
• Importance of preoperative cognitive screening

Mood and Behavior:

• Depression management (may improve or worsen)
• Apathy recognition and treatment
• Impulse control monitoring
• Sleep quality assessment

Quality of Life Measures

PDQ-39 Domains:

• Mobility
• Activities of daily living
• Emotional well-being
• Stigma
• Social support
• Communication
• Cognition
• Bodily discomfort

Technical Considerations and Future Directions

Hardware Development

Next-Generation Systems:

• Directional leads (steerable electric fields)
• Chronic recording capabilities
• Rechargeable batteries
• Wireless connectivity
• Fully implantable systems

Sensing Capabilities:

• Local field potential recording
• Chronic biomarker monitoring
• Closed-loop integration
• Remote programming options

Computational Approaches

Machine Learning Integration:

• Patient-specific symptom clustering
• Optimized parameter prediction
• Long-term outcome modeling
• Biomarker pattern recognition

Personalized Medicine:

• Individual circuit mapping
• Customized stimulation protocols
• Genotype-phenotype correlations
• Precision targeting algorithms

Trial Methodology

Observational Design

The observational design allows:

Data Collection:

• Natural variation observation
• Without intervention effects
• Longitudinal tracking

Patient Selection:

• DBS candidates
• PD diagnosis
• Motor症状 assessment

Neural Recordings

Recording Sites:

• Motor cortex
• Subthalamic nucleus
• Pallidum

Analysis:

• Single-unit activity
• Local field potentials
• Cortical rhythms

Motor Circuit Function

Reach-Related Modulation

The trial studies:

Motor Preparation:

• Movement planning
• Execution initiation
• Movement modulation

Circuit Changes:

• Activity patterns
• Timing relationships
• Synchronization

Cognitive Integration

Motor and cognitive circuits interact:

N-Back Task:

• Working memory assessment
• Cognitive load
• Motor interference

Circuit Integration:

• Cortico-striatal loops
• Prefrontal involvement
• Motor sequencing

Clinical Implications

Personalized Medicine

Circuit-based approaches enable:

Target Selection:

• Individual anatomy
• Symptom profiles
• Circuit mapping

Parameter Optimization:

• Stimulation sites
• Frequency selection
• Intensity tuning

Future Directions

Circuit-based DBS may lead to:

Closed-Loop Systems:

• Real-time adaptation
• Automatic adjustment
• Patient-specific settings

Cognitive Treatment:

• Non-motor symptoms
• Mood effects
• Autonomic function

Safety Considerations

DBS Safety Profile

Established safety considerations:

Surgical Risks:

• Infection
• Hemorrhage
• Hardware complications

Stimulation Effects:

• SpeechEffects
• Mood changes
• Gait effects

Monitoring

Patient monitoring includes:

• Motor assessments
• Cognitive testing
• Quality of life

Research Significance

contribution to PD Understanding

This trial advances:

Circuit Understanding: Mapping specific circuits

Treatment Optimization: Personalized approaches

Mechanism Insights: Disease understanding

Broader Applications

Circuit-based approaches may apply to:

• Essential tremor
• Dystonia
• Epilepsy
• Psychiatric disorders

Related Pages

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Deep Brain Stimulation](/therapeutics/deep-brain-stimulation)
• [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
• [Subthalamic Nucleus](/cell-types/subthalamic-nucleus)
• [Globus Pallidus](/cell-types/globus-pallidus)
• [Motor Cortex](/cell-types/motor-cortex)
• [Clinical Trials in Parkinson's Disease](/clinical-trials/parkinsons-disease)

External Links

• [ClinicalTrials.gov - NCT05658302](https://clinicaltrials.gov/study/NCT05658302)
• [University of Minnesota Medical School](https://med.umn.edu/)
• [Parkinson's Foundation - DBS](https://www.parkinson.org/Life-with-Parkinsons/Treatment-Surgery/Alternatives-to-Levodopa/Deep-Brain-Stimulation)

References

[NCT05658302 - Circuit-Based Deep Brain Stimulation for Parkinson's Disease](https://clinicaltrials.gov/study/NCT05658302)

[University of Minnesota - Parkinson's Disease Research](https://www.mhealth.org/)

[Adaptive Deep Brain Stimulation - Nature Reviews Neurology](https://doi.org/10.1038/s41582-020-00456-3)

[Circuit Dynamics Underlying Motor Symptoms in Parkinson's Disease - Brain](https://doi.org/10.1093/brain/awab123)

[Deep brain stimulation for Parkinson's disease - mechanisms](https://pubmed.ncbi.nlm.nih.gov/)

[Closed-loop DBS systems - recent advances](https://pubmed.ncbi.nlm.nih.gov/)

Pathway Diagram